464490.KQ QuadMedicine, Inc.
- Market cap
- KRW 47.1B
- P/E
- -
- P/B
- -
- ROE
- -
- Dividend yield
- -
- Fundamental score
- -
Is 464490.KQ undervalued?
Graham numberThe Graham number of QuadMedicine, Inc. cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
QuadMedicine, Inc. fundamental analysis
No fundamental analysis for QuadMedicine, Inc. yet.
QuadMedicine, Inc. stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About QuadMedicine, Inc.
QuadMedicine, Inc. engages in research, development, and production of healthcare vaccination needles based on the microneedle array patch (MAP). The company develops vaccinations for children living in remote areas to protect them from infectious diseases, such as diphtheria, tetanus, polio, measles, and hepatitis B. The company focuses on technology integration for medical and pharmaceutical microneedle development. It also provides fundamental MAP research through prototy…
Full company profileFinancial statements of QuadMedicine, Inc. are not available yet.
QuadMedicine, Inc. dividends
QuadMedicine, Inc. has not paid dividends in the last 1 fiscal years.
Who owns QuadMedicine, Inc.
- Insiders 30.75%
- Institutions 5.63%
- Public & others 63.62%
- Shares outstanding 11.3M
- Free float 7.62M
QuadMedicine, Inc. company profile
- Company name
- QuadMedicine, Inc.
- Ticker
- 464490.KQ
- Exchange
- KOSDAQ
- Sector
- Healthcare
- Industry
- Medical Instruments & Supplies
- Employees
- 104
- Fiscal year end
- December
- Address
- Suite 605, Seongnam-si, South Korea, 13209
- Phone
- 82 3 1754 1152
- Website
- quadmedicine.com/en
About QuadMedicine, Inc.
QuadMedicine, Inc. engages in research, development, and production of healthcare vaccination needles based on the microneedle array patch (MAP). The company develops vaccinations for children living in remote areas to protect them from infectious diseases, such as diphtheria, tetanus, polio, measles, and hepatitis B. The company focuses on technology integration for medical and pharmaceutical microneedle development. It also provides fundamental MAP research through prototyping to MAP production for clinical trials. The company was incorporated in 2016 and is headquartered in Seongnam-si, South Korea.
QuadMedicine, Inc. management
6- Mr. Seung-Ki BaekFounder, CEO & Director · born 1982
- Mr. Young-heung KimCFO & Director · born 1982
- Dr. Jung-Hwan ParkCTO & Director · born 1967
- Ms. SinAe HyunDirector of Human Resources & Public Relations · born 1985
- Ms. Hyeseon JeonHead of Strategic Planning Division · born 1989
- Mr. GilHwan SungHead of Management Support Division · born 1982